XWEL.NASDAQXwell, INC

10-K/A: XWELL, Inc. Files Amendment No. 1 to Form 10-K/A for Fiscal Year Ended December 31, 2024

Sentiment:

Form 10-K/A Amendment


XWELL, Inc. amends its original Form 10-K filing to include Part III information and updated certifications due to the absence of a definitive proxy statement.

Summary

  • XWELL, Inc. filed Amendment No. 1 to its Annual Report on Form 10-K/A for the fiscal year ended December 31, 2024.
  • The amendment includes information required by Part III of the original filing, which was omitted because the company did not file a definitive proxy statement within 120 days after the end of its 2024 fiscal year.
  • The amendment also includes new certifications by the principal executive officer and principal financial and accounting officer under Section 302 of the Sarbanes-Oxley Act of 2002.
  • The original filing was submitted on April 15, 2025.
  • The company's common stock is traded on the Nasdaq Stock Market LLC under the ticker symbol XWEL.
  • As of April 25, 2025, there were 5,261,024 shares of the company's common stock outstanding.
  • The aggregate market value of the registrant’s voting common stock held by non-affiliates as of June 30, 2024 was $7,535,583.
  • The company's auditor is Marcum LLP, located in New York, NY.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It includes necessary information about corporate governance and executive compensation, but does not contain any particularly positive or negative news.

Positives

  • The company has a majority of independent directors on its board.
  • The company has established key committees to oversee important aspects of its business, including audit, compensation, and corporate governance.
  • The company has a Code of Conduct and Ethics in place.
  • The company has an insider trading policy to promote compliance with insider trading laws.

Negatives

  • The company did not file a definitive proxy statement within 120 days after the end of its 2024 fiscal year, necessitating the amendment.
  • Gaelle Wizenberg reported late on form 4 the purchase of 100 shares of Common Stock on April 26, 2024, and on May 7, 2024, Ms. Wizenberg purchased 199 shares of Common Stock.

Risks

  • The document contains forward-looking statements that are subject to risks and uncertainties.
  • The company's future performance may differ materially from expectations due to various factors.
  • The company's risk factors are detailed in Item 1A of the original filing and in quarterly and current reports.

Future Outlook

The document does not contain specific forward-looking guidance, but it refers to the cautionary note regarding forward-looking statements in the original filing and subsequent reports.

Industry Context

The document does not provide specific industry context beyond the company's operations.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Executive OfficerScott R. MilfordEzra T. ErnstSeptember 4, 2024Milford stepped down as President and Chief Executive Officer
Chief Financial OfficerSuzanne A. ScrabisThomas Ian BrownJanuary 8, 2025Scrabis resigned as Chief Financial Officer
Board MemberDonald E. StoutGalle WizenbergJanuary 1, 2024Stout ceased to be a member of the Board of Directors and all committees thereto, including the Audit Committee. As of January 30, 2024, Galle Wizenberg was elected to be a member of the Audit Committee.

Key Dates

DateDescription
February 5, 2018Bruce T. Bernstein appointed as the non-executive Chairman of the Board of Directors.
May 4, 2020Friedman LLP approved as independent registered public accounting firm.
April 26, 2024Gaelle Wizenberg purchased 100 shares of Common Stock.
May 7, 2024Gaelle Wizenberg purchased 199 shares of Common Stock.
June 30, 2024Aggregate market value of non-affiliate voting common stock was $7,535,583.
September 4, 2024Ezra T. Ernst appointed as President and Chief Executive Officer.
December 31, 2024End of fiscal year 2024.
January 1, 2024Donald E. Stout ceased to be a member of the Board of Directors and all committees.
January 2, 2025Suzanne A. Scrabis entered into a Resignation, Separation Agreement and Release.
January 8, 2025Suzanne A. Scrabis's resignation as Chief Financial Officer became effective.
April 15, 2025Original Form 10-K filing date.
April 25, 20255,261,024 shares of common stock outstanding.
April 28, 2025Amendment No. 1 to Form 10-K/A signed.

Keywords

corporate governance, executive compensation, directors, financial statements, XWELL, 10-K/A

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.